🔎 Trials Near Me

Почетна › Метастатски карцином › Вашингтон › Seattle

Kliničke studije za Метастатски карцином u gradu Seattle, WA

39 studija za Метастатски карцином traži učesnike na lokacijama u gradu Seattle i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Тражи се учесникФаза 2
  • Swedish Medical Center-First Hill, Seattle
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT05564377

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Тражи се учесникФаза 1
  • Fred Hutchinson Cancer Research Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04886804

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Тражи се учесникФаза 1/2
  • Virginia Mason Medical Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07020221

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Тражи се учесникФаза 2
  • Fred Hutchinson Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07007559

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Тражи се учесникФаза 3
  • Virginia Mason Medical Center, Seattle
  • University of Washington Fred Hutchinson Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07562152

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Тражи се учесникФаза 1/2
  • Fred Hutchinson Cancer Center, Seattle
Узраст 12 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT05384626

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Тражи се учесникФаза 3
  • Swedish Medical Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07174336

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Тражи се учесникФаза 3
  • Swedish Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213804

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Тражи се учесникФаза 3
  • Swedish Medical Center, Seattle
  • VA Puget Sound Health Care System, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Тражи се учесникФаза 2/3
  • Fred Hutchinson Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06943755

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1/2
  • Fred Hutchinson Cancer Center / University of Washington, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT04657068

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Тражи се учесникФаза 1
  • Fred Hutchinson Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06521554

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Тражи се учесникФаза 1/2
  • Avenzo Therapeutics Recruiting Site, Seattle
Узраст од 18 до 75 · Оба пола · Ажурирано 16. 10. 2026. · NCT07038343

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Тражи се учесникФаза 2/3
  • Virginia Mason Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06989437

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Тражи се учесникФаза 3
  • Fred Hutchinson Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06757634

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

Тражи се учесникФаза 1/2
  • Fred Hutchinson Cancer Center ( Site 0013), Seattle
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06863272

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Тражи се учесникФаза 1/2
  • Fred Hutchinson Cancer Center, Seattle
  • University Of Washington Medical Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07227415

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Тражи се учесникФаза 3
  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • Swedish Medical Center, Seattle
  • и још 1
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222800

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Тражи се учесникФаза 1
  • Swedish Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT06234605

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Тражи се учесникФаза 1/2
  • University of Washington, Fred Hutchinson Cancer Center, Seattle
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Тражи се учесникФаза 1
  • Fred Hutchinson Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 1. 10. 2026. · NCT06625775

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Тражи се учесникФаза 1
  • Swedish Cancer Institute, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07277413

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Тражи се учесникФаза 1/2
  • University of Washington / Fred Hutchinson Cancer Center, Seattle
Узраст 12 и старији · Оба пола · Ажурирано 24. 9. 2026. · NCT05118789

SLV-154 Treatment of Advanced Cancers

Тражи се учесникФаза 1
  • University of Washington / Fred Hutchinson Cancer Center, Seattle
Узраст 12 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT06771219

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

Тражи се учесникФаза 1
  • Fred Hutchinson Cancer Research Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 24. 8. 2026. · NCT06803680

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Тражи се учесникЗдраве особе су добродошле
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT04515810

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

Тражи се учесникФаза 1
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center - Montlake, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 3. 8. 2026. · NCT05687110

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Тражи се учесникФаза 3
  • Research Site, Seattle
Узраст 18 и старији · Жене · Ажурирано 29. 7. 2026. · NCT07044336

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Тражи се учесникФаза 1
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT05098210

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Тражи се учесникФаза 2
  • VA Puget Sound Health Care System, Seattle
Узраст 18 и старији · Мушкарци · Ажурирано 15. 6. 2026. · NCT05422911

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Тражи се учесникФаза 1
  • Fred Hutchinson Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 2. 6. 2026. · NCT06917079

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Тражи се учесникФаза 1/2
  • Virginia Mason Medical Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 15. 5. 2026. · NCT05379985

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Тражи се учесникФаза 2/3
  • Fred Hutchinson Cancer Research Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 17. 4. 2026. · NCT06947928

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Тражи се учесникФаза 2/3
  • Fred Hutchinson Cancer Center, Seattle
Сви узрасти · Оба пола · Ажурирано 2. 4. 2026. · NCT06581406

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Тражи се учесникФаза 1
  • Fred Hutchinson Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 13. 2. 2026. · NCT06778863

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

Тражи се учесникФаза 1
  • Fred Hutchinson Cancer Center, Seattle
Узраст од 18 до 99 · Оба пола · Ажурирано 3. 12. 2025. · NCT07021898

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Тражи се учесникОпсервациона студија
  • Massive Bio SYNERGY-AI site, Seattle
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Тражи се учесникФаза 1
  • Fred Hutch Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 25. 9. 2025. · NCT05808634

A Study of NX-1607 in Adults With Advanced Malignancies

Тражи се учесникФаза 1
  • Fred Hutchinson Cancer Center, Seattle
Узраст 18 и старији · Оба пола · Ажурирано 9. 9. 2025. · NCT05107674

Studije za Метастатски карцином u drugim gradovima

Ostale studije u gradu Seattle

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.